Home > Boards > US Listed > Medical - Drugs > Oramed Pharmaceuticals (ORMP)

News: $ORMP Oramed Patent Allowed in the U.S.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 57
Posts 7,185
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/11/2019 4:53:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/6/2019 6:02:01 AM
Oramed Appoints Dr. Arie Mayer to Board of Directors PR Newswire (US) - 12/5/2019 9:12:00 AM
Oramed to Present a Scientific Poster at International Diabetes Federation Congress PR Newswire (US) - 12/2/2019 8:25:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 11/27/2019 4:28:28 PM
Oramed Patent Granted in Japan for Protease Inhibitor, a Key Component of Platform Technology PR Newswire (US) - 11/21/2019 8:27:00 AM
Oramed Provides Highlights and Data From Its Phase IIb Oral Insulin Study Investor Event PR Newswire (US) - 11/19/2019 8:55:00 AM
Oramed Pharmaceuticals to Discuss Positive Phase IIb Data at Investor Event and Conference Call on Monday, November 18th PR Newswire (US) - 11/14/2019 7:28:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 7:04:56 AM
Oramed Announces Successful Phase IIb Study of Oral Insulin in Type 2 Diabetes PR Newswire (US) - 11/12/2019 7:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 10/23/2019 4:36:39 PM
Oramed to Present at Ladenburg Thalmann 2019 Healthcare Conference PR Newswire (US) - 9/18/2019 8:38:00 AM
Oramed Announces Last Patient Treated in Pivotal Phase IIb Trial of Oral Insulin ORMD-0801 PR Newswire (US) - 9/17/2019 8:40:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:09:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:08:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:07:48 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/16/2019 6:07:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:07:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 6:06:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 5:18:02 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/5/2019 4:49:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/5/2019 4:42:36 PM
Oramed to Present at Three Upcoming Conferences PR Newswire (US) - 9/3/2019 8:25:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/21/2019 5:28:25 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/6/2019 1:29:52 PM
whytestocks Member Level  Thursday, 03/28/19 02:40:40 PM
Re: None
Post # of 525 
News: $ORMP Oramed Patent Allowed in the U.S. for Key Aspect of Its Oral Delivery Technology

NEW YORK , March 28, 2019 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that its U.S. patent for the technology "Protease...

Find out more https://marketwirenews.com/news-releases/oramed-patent-allowed-in-the-u-s-for-key-aspect-of-its-oral-delivery-technology-7906106.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist